EQRx - International Biopharmaceutical Industry

Current Edition

news

EQRx builds case for cancer drug it hopes can disrupt market

Dive Brief: EQRx, which aims to bring new medicines to market at "radically lower" prices, said the experimental lung cancer drug it co-owns with Chinese biotech C...

20 January 2022 news cancer | Drug

Continue Reading →

news

Startup EQRx to take drug price mission public through $1.8B SPAC deal

EQRx, a startup with lofty ambitions to develop competitors to top-selling drugs at much reduced prices, will go public through a merger with a blank-check company ba...

13 August 2021 news Biotech | Casdin Capita

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

EQRx builds case for cancer drug it hopes can disrupt market

Startup EQRx to take drug price mission public through $1.8B SPAC deal

International Biopharmaceutical Industry